drugset
drugset / Trial / NCT02205879

Pregabalin for Alcohol Dependence

NCT02205879 ↗

Phase 4 Completed 100 enrolled St. Petersburg Bekhterev Research Psychoneurological Institute St.-Petersburg Bekhterev Research Psychoneurological Institute, Russian Federation · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study hypothesis is: Pregabalin is superior to placebo in preventing relapse to drinking and reducing drinking severity

Timeline

Start
2013-01
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule — —

Indications

alcohol dependence